FOR PROFESSIONALS
Case Managers, Deputies & Clinical Teams
A Structured Clinical Service for Complex ABI Cases
CANN-ABI works alongside professional networks supporting individuals with Acquired Brain Injury (ABI), particularly where behavioural instability, treatment resistance or safeguarding risks are present.
Our service integrates prescribing within a formal governance framework suitable for medico-legal environments.
WHO WE WORK WITH
We regularly collaborate with:
• Case Managers
• Court-Appointed Deputies
• Solicitors and litigation teams
• Rehabilitation providers
• Psychiatrists and neurologists
• Local authority safeguarding teams
• Residential care providers
Referrals are typically made where conventional interventions have not achieved adequate stabilisation.
WHEN TO CONSIDER REFERRAL
Indicators That Specialist Assessment May Be Appropriate
Behavioural Instability
Aggression, agitation, impulsivity or emotional volatility affecting placement stability.
Treatment Resistance
Limited response or intolerable side effects from standard pharmacological interventions.
Sleep Dysregulation
Persistent insomnia contributing to daytime behavioural deterioration.
MDT Management Complexity
Cases requiring coordinated clinical oversight across disciplines.
Exploitation Vulnerability
Increased risk of coercion, financial abuse or unsafe associations.
Illicit Cannabis Use
Existing street cannabis use posing safeguarding or legal risks.
BEST INTERESTS & CAPACITY SUPPORT
Where capacity is impaired, we provide:
• Formal Mental Capacity assessments
• Written Best Interests rationale
• MDT consultation input
• Deputy liaison
• Documentation suitable for Court scrutiny
All decisions align with the Mental Capacity Act 2005.
STRUCTURED GOVERNANCE & REPORTING
Professionals receive clear documentation including:
• Initial assessment reports
• Treatment rationale
• Risk-benefit formulation
• Monthly monitoring summaries
• Escalation notifications where required
Tier 2 cases may include court-ready clinical summaries.
A MEDICAL-LEGAL-AWARE SERVICE MODEL
Cann-ABI is designed to operate within deputyship and litigation frameworks.
RISK MANAGEMENT & SAFEGUARDING FOCUS
ABI patients may present complex safeguarding concerns.
Our monitoring framework includes:
Exploitation Risk
Indicators of financial abuse, coercion or “cuckooing.”
Forensic Risk Reduction
Stabilisation of behaviour to reduce involvement with criminal justice pathways.
Engagement with Rehabilitation
Monitoring whether treatment supports participation in therapy and daily structure.
Community Safety
Assessment of risks to others where behavioural dyscontrol is present.
HARM REDUCTION APPROACH
Where illicit cannabis use exists, structured prescribing may:
• Replace unregulated substances
• Reduce exposure to high-potency products
• Decrease exploitation risk
• Enable clinical monitoring
• Improve stability
This approach is carefully assessed and not applied universally.
HOW WE WORK WITH YOUR MDT
Cann-ABI integrates with existing care teams rather than operating in isolation.
Communication pathways may include:
• Case Manager liaison
• Deputy updates
• GP notification (100% compliance)
• Collaboration with treating psychiatrists
• Rehabilitation team input
Treatment plans are aligned with the broader care strategy.
LEGAL & REGULATORY COMPLIANCE
Cann-ABI integrates with existing care teams rather than operating in isolation.
Communication pathways may include:
• Case Manager liaison
• Deputy updates
• GP notification (100% compliance)
• Collaboration with treating psychiatrists
• Rehabilitation team input
Treatment plans are aligned with the broader care strategy.
TIERED CARE MODEL
Care That Matches Neuro-Behavioural Stability
Sustain Tier
From £300/month
For stable patients requiring nurse-led monitoring and script authorisation.
Includes:
• Monthly nurse review (20 mins)
• Monthly script authorisation
• Deputy liaison support
Complex Care Tier
From £600/month
For higher-risk or unstable neuro-behavioural presentations.
Includes:
• Monthly psychiatrist review (30–45 mins)
• Enhanced MDT reporting
• Intensive oversight
REFERRAL PROCESS FOR PROFESSIONALS
Step 1 — Initial Discussion
We encourage case discussion prior to formal referral for complex cases.
Step 2 — Referral Submission
Submission of referral details and relevant documentation.
Step 3 — Eligibility & Capacity Review
Verification of treatment resistance and governance requirements.
Step 4 — Assessment Scheduling
Appointment arranged where criteria are met.